Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Table of Contents

December 01, 2016; Volume 83,Issue 12

From the Editor

  • You have access
    Hiding in clear sight: Complications of immunosuppressive therapies
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine December 2016, 83 (12) 862-863; DOI: https://doi.org/10.3949/ccjm.83b.12016

    Immunosuppressive drugs can mask the signs of deep infection and thus delay its diagnosis.

The Clinical Picture

  • You have access
    Phlegmasia cerulea dolens from radiation-induced venous stenosis
    Suman Paul, MBBS, PhD and Mujeeb Sheikh, MD
    Cleveland Clinic Journal of Medicine December 2016, 83 (12) 865-867; DOI: https://doi.org/10.3949/ccjm.83a.15166

    The patient had received pelvic radiation 10 years earlier for prostate cancer.

  • You have access
    Abdominal pain under immunosuppressive conditions
    Takayo Ota, MD, PhD, Masanobu Nakano, MSc, Noriko Tanaka, MD, Tomohiro Suzumura, MD, PhD, Nozomi Miyatake, BPharm, Yoshikazu Hasegawa, MD, PhD, Tomohiro Ozaki, MD, Hiroshi Tsukuda, MD and Masahiro Fukuoka, MD, PhD
    Cleveland Clinic Journal of Medicine December 2016, 83 (12) 874-875; DOI: https://doi.org/10.3949/ccjm.83a.15143

    A cancer patient receiving corticosteroids for a brain metastasis developed emphysematous cystitis and psoas muscle abscess.

  • You have access
    Minocycline-induced hyperpigmentation
    Mahmoud Abdelghany, MD and Alan J. Kivitz, MD
    Cleveland Clinic Journal of Medicine December 2016, 83 (12) 876-877; DOI: https://doi.org/10.3949/ccjm.83a.16058

    The patient presented with extensive bluish skin discoloration that had started 1 year earlier as a small area and then spread.

Smart Testing

  • You have access
    What stool testing is appropriate when diarrhea develops in a hospitalized patient?
    Sheena K. Ramdeen, MD, MPH and Glenn W. Wortmann, MD, FIDSA, FACP
    Cleveland Clinic Journal of Medicine December 2016, 83 (12) 882-884; DOI: https://doi.org/10.3949/ccjm.83a.16039

    Most cases are not due to infection, but Clostridium difficile is the most common infectious cause.

1-Minute Consult

  • You have access
    When should an indwelling pleural catheter be considered for malignant pleural effusion?
    Abdul Hamid Alraiyes, MD, FCCP, Kassem Harris, MD, FCCP and Thomas R. Gildea, MD, MS, FCCP
    Cleveland Clinic Journal of Medicine December 2016, 83 (12) 891-894; DOI: https://doi.org/10.3949/ccjm.83a.15075

    Consider catheter placement if symptoms and effusions recur or if pleurodesis fails.

Review

  • You have access
    Taurine, energy drinks, and neuroendocrine effects
    Jonathan J. Caine, MD and Thomas D. Geracioti, MD
    Cleveland Clinic Journal of Medicine December 2016, 83 (12) 895-904; DOI: https://doi.org/10.3949/ccjm.83a.15050

    Taurine is a major ingredient in popular energy drinks, but little is known about its neuroendocrine effects.

  • You have access
    Women’s health 2016: An update for internists
    Pelin Batur, MD, NCMP, CCD, Eleanor Bimla Schwarz, MD, MS, Judith M. E. Walsh, MD, MPH and Kay M. Johnson, MD, MPH
    Cleveland Clinic Journal of Medicine December 2016, 83 (12) 905-913; DOI: https://doi.org/10.3949/ccjm.83a.16098

    Important studies of urinary tract infections, bisphosphonates, ovarian cancer screening, and contraception.

  • You have access
    Radiation-induced heart disease: A practical guide to diagnosis and management
    Eoin Donnellan, MD, Dermot Phelan, MD, PhD, Cian P. McCarthy, MD, Patrick Collier, MD, PhD, Milind Desai, MD and Brian Griffin, MD
    Cleveland Clinic Journal of Medicine December 2016, 83 (12) 914-922; DOI: https://doi.org/10.3949/ccjm.83a.15104

    Unfortunately, radiotherapy for breast cancer or lymphoma can damage the heart.

  • Do patients with submassive pulmonary embolism benefit from thrombolytic therapy?
    You have access
    Do patients with submassive pulmonary embolism benefit from thrombolytic therapy?
    Ali Ataya, MD, Jessica Cope, PharmD, Abbas Shahmohammadi, MD and Hassan Alnuaimat, MD
    Cleveland Clinic Journal of Medicine December 2016, 83 (12) 923-932; DOI: https://doi.org/10.3949/ccjm.83a.15116

    The risk of hemorrhage is signifi cant, and the benefi t is unclear. A one-treatment-for-all approach cannot be applied.

Editorial

  • You have access
    Thrombolysis in submassive pulmonary embolism: Finding the balance
    Carlos L. Alviar, MD and Gustavo A. Heresi, MD
    Cleveland Clinic Journal of Medicine December 2016, 83 (12) 933-936; DOI: https://doi.org/10.3949/ccjm.83a.16099

    In massive pulmonary embolism, thrombolytic therapy is usually indicated; in submassive cases the decision is not so clear.

Back to top
PreviousNext

In this issue

Cleveland Clinic Journal of Medicine: 83 (12)
Cleveland Clinic Journal of Medicine
Vol. 83, Issue 12
1 Dec 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Sign up for alerts

Jump to

  • From the Editor
  • The Clinical Picture
  • Smart Testing
  • 1-Minute Consult
  • Review
  • Editorial
  • Editor's Picks
  • Most Cited
  • Most Read
Loading
The beat goes on: Highlights from the new American and European A-fib guidelines
What diagnostic tests should be done after discovering clubbing in a patient without cardiopulmonary symptoms?
Tinea incognito
Prolonged venous filling time and dependent rubor in a patient with peripheral artery disease
Nociplastic pain: A practical guide to chronic pain management in the primary care setting
Sarcoidosis with diffuse purplish erythematous plaques on the hands
Cardiovascular disease in people living with HIV: Risk assessment and management
Heart to heart: Progress in cardiovascular disease prevention for people living with HIV
Don’t judge a book by its cover: Unusual presentations of pericardial disease
Hypoglycemia after bariatric surgery: Management updates
Risk-factor modification to prevent recurrent atrial fibrillation after catheter ablation
Common electrolyte imbalance, uncommon cause

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire